Belumosudil 200mg tablets
NHS hospitals in England used £28,432,752 of indicative cost of Belumosudil 200mg tablets in the 12 months to July 2026, about 0.1% of all hospital medicines spend. That is up 24.5% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Belumosudil 200mg tablets: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Belumosudil 200mg tablets most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| The Royal Marsden Nhs Foundation Trust | £2,924,688 |
| Univ Hpl B/Ham Nhs Foundation Trust | £2,837,484 |
| Manchester University Nhs Ft | £2,674,480 |
| The Clatterbridge Cancer Centre Nhs Ft | £2,528,916 |
| Barts Health Nhs Trust | £2,197,094 |
| Nottingham University Hospitals Trust | £2,045,493 |
| Imperial College Healthcare Nhs Trust | £1,801,769 |
| University Hospital Southampton Nhs Ft | £1,744,080 |
| Oxford University Hospitals Nhs Ft | £1,588,007 |
| University Hpls Of Leicester Nhs Trust | £1,395,264 |
The primary-care picture
Belumosudil is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Belumosudil medicine page.